EP Patent

EP0916347A1 — Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances

Assigned to UNI-PHARMA KLEON TSETIS A.B.E.E.,FARMAKEFTIKA ERGA · Expires 1999-05-19 · 27y expired

What this patent protects

These solutions comprise as active ingredient or ingredients Paracetamol and combinations of Paracetamol with the spasmolytic HYOSCINE-N-BUTYLBROMIDE and the analgesic CODEINE PHOSPHATE where the solvent in all cases consists of Ethanol, bis-distilled and sterilized Water and GLY…

USPTO Abstract

These solutions comprise as active ingredient or ingredients Paracetamol and combinations of Paracetamol with the spasmolytic HYOSCINE-N-BUTYLBROMIDE and the analgesic CODEINE PHOSPHATE where the solvent in all cases consists of Ethanol, bis-distilled and sterilized Water and GLYCEROL FORMAL or Benzyllic Alcohol, Water and GLYCEROL FORMAL in the ratio of 10,40 κα 50% by volume. The solution is also comprised of LIDOCAINE as local anaesthetic and DISODIUM EDETATE , SODIUM METABISULFITE, SODIUM DIBASIC PHOSPHATE, NIPAGIN A and NIPASOL M, excipients assuring solutions stability and maintenance of pH in the desired limits of 5,0 - 6,5.

Drugs covered by this patent

Patent Metadata

Patent number
EP0916347A1
Jurisdiction
EP
Classification
—
Expires
1999-05-19
Drug substance claim
No
Drug product claim
No
Assignee
UNI-PHARMA KLEON TSETIS A.B.E.E.,FARMAKEFTIKA ERGA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.